Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program

Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects

NCT02073812 ·Status: COMPLETED ·Phase: PHASE1

A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia

NCT00002103 ·Status: COMPLETED ·Phase: NA

Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia

NCT03027609 ·Status: COMPLETED ·Phase: PHASE2

Ascending Dose Study of FrontlineODP™ Spray Dried Plasma

NCT05629338 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support

NCT04429334 ·Status: COMPLETED ·Phase: PHASE2

The Clinical Study of Carrimycin on Treatment Patients With COVID-19

NCT04286503 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

NCT03182504 ·Status: COMPLETED ·Phase: PHASE1

COVID-19 SAFE Enrollment

NCT04506268 ·Status: COMPLETED ·Phase: NA

An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects

NCT01267968 ·Status: COMPLETED ·Phase: PHASE1

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

NCT01853982 ·Status: TERMINATED ·Phase: PHASE3

Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19

NCT05212662 ·Status: WITHDRAWN ·Phase: PHASE2

TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients

NCT04716556 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects

NCT01751269 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

NCT04880694 ·Status: COMPLETED ·Phase: PHASE2

A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)

NCT00002434 ·Status: COMPLETED ·Phase: NA

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

NCT01262885 ·Status: COMPLETED ·Phase: PHASE1

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

NCT04860505 ·Status: COMPLETED ·Phase: PHASE4

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

NCT01772836 ·Status: COMPLETED ·Phase: PHASE1

Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)

NCT04295551 ·Status: UNKNOWN ·Phase: NA

PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB

NCT05685615 ·Status: COMPLETED ·Phase: PHASE2

Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia

NCT04348448 ·Status: TERMINATED

A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects

NCT03612557 ·Status: COMPLETED ·Phase: PHASE1

Imipenem and Sulbactam in the Treatment of Imipenem-resistant Acinetobacter Baumannii Bacteremia

NCT01374256 ·Status: UNKNOWN

Special Use-Result Surveillance of Unasyn-S (Kit) for Intravenous Use - A Surveillance on High-dose (>6 g Daily) Administration -

NCT01793688 ·Status: COMPLETED

Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia

NCT05057221 ·Status: TERMINATED ·Phase: PHASE1/PHASE2